1、该刊只有国际刊号。

2、投稿方式：官网投稿。

3、官网网址（中华医学期刊网信息）：

https://jnmmi.theimms.com/（投稿）

https://www.yiigle.com/Journal/JNMMI

4、官网电话：0510-6808883

5、官网邮箱：jnmmi@cmaph.org

6、出刊日期：季刊，一年出版四期。

7、官网信息：2025-2027年免收文章处理费。

2025年12月31日星期三

Instructions for Authors

【官网信息】

About the Journal

The

Journal of Nuclear Medicine and Molecular Imaging (JNMMI), the official

journal of the Chinese Society of Nuclear Medicine, is an

international, peer-reviewed, open-access journal dedicated to advancing

research and clinical applications in nuclear medicine and molecular

imaging. Launched in September 2025, JNMMI is published quarterly (64

pages per issue) in English, available in both print and online formats.

The journal serves as a platform for scholars, clinicians, and industry

professionals to share cutting-edge discoveries and innovations,

fostering interdisciplinary dialogue to accelerate the translation of

scientific breakthroughs into clinical practice, particularly in

oncology, cardiology, neurology, and related fields. The journal allows

free access to its contents and permits authors to self-archive the

final accepted version of the articles on any OAI-compliant

institutional/subject-based repository.

Scope of the Journal

JNMMI welcomes high-quality submissions in nuclear medicine and molecular imaging, including:

Clinical applications and translational studies in nuclear medicine.

Basic research in radiopharmaceuticals and molecular imaging.

Development and preclinical/clinical validation of novel molecular probes.

Advances in nuclear imaging technology and equipment, with emphasis on clinical significance.

Types of Manuscripts

JNMMI welcomes the following types of manuscripts:

Original

Research: Includes experimental studies, clinical research, and

epidemiological studies (up to 5,000 words, excluding abstract,

references, and tables).

Structured abstract (300 words): Background, Methods, Results, Conclusions.

3–6 keywords.

Approximately 30 references, preferably from the last 5 years.

Review

Article: Systematic reviews on current techniques, therapies, clinical

trials, or emerging research (up to 5,000 words excluding tables,

references and abstract for standard reviews, with up to 90 references;

20,000–30,000 words for comprehensive reviews, with up to 350

references).

Indicative abstract (150–250 words).

3–6 keywords.

Systematic reviews must include a methods section (data location, selection, extraction, and synthesis).

Interesting

Cases: Reports of unique or noteworthy clinical cases demonstrating

innovative applications of nuclear medicine and molecular imaging (up to

1,000 words).

Concise descriptive summary with a representative image.

3–6 keywords.

Up to 5 references, 2 tables or figures.

Declaration of patient consent if patient information is included.

Guidelines

and Consensus: Articles that present or analyze current clinical

practice guidelines, consensus statements, or best practices in the

field (flexible length based on organizational standards).

Abstract (150–250 words) describing development, recommendations, and scope.

3–6 keywords.

Include a concise table or graphic summarizing key points.

Editorials: Invited opinion articles, academic discussions, and special commentaries (up to 2,000 words).

Up to 25 references.

No abstract or keywords.

The Editorial Process

Manuscripts

are reviewed with the understanding that they are submitted exclusively

to JNMMI, have not been published elsewhere, and are not under

consideration elsewhere. The editorial process includes:

Initial

Screening: Editors assess manuscripts for originality, scientific

quality, and relevance to nuclear medicine and molecular imaging.

Manuscripts lacking novelty, with serious flaws, or not aligned with

JNMMI’s scope may be rejected before peer review.

Peer

Review: JNMMI employs a single-blind peer review process (reviewers

know authors’ identities, but authors do not know reviewers’

identities). Manuscripts are evaluated based on:

Novelty and scientific quality.

Rigor of experimental design and reliability of results.

Clarity of structure and writing.

Comprehensive discussion of existing literature.

The review process typically takes 6–8 weeks, depending on reviewer availability and manuscript volume.

Revisions:

Authors receive reviewers’ comments and must submit a point-by-point

response with revisions. Changes should be marked (e.g., underlined or

colored text).

Copy

Editing: Accepted manuscripts undergo copy editing for grammar,

punctuation, and format. Page proofs are sent to the corresponding

author, who must return corrections within 7 days.

Online

Publication: Accepted articles are published online as “Ahead of Print”

to ensure rapid dissemination, aligned with the journal’s quarterly

schedule (64 pages per issue).

Submission Instructions

All

manuscripts must be submitted via the JNMMI online submission system

(https://jnmmi.theimms.com). Authors must register on the website and

use their account to track submissions. Submissions should include:

File Format: Manuscripts must be in Microsoft Word (.doc/.docx).

Title Page: Include:

Manuscript type and title.

Full names, affiliations, and contact details of all authors.

Corresponding author’s name, email, and phone number.

Word counts for abstract and main text (excluding references, tables, and figures).

Funding sources, acknowledgments, and conflict of interest disclosures.

Statement confirming all authors have read and approved the manuscript.

Details of prior presentations or related submissions.

Author contributions (e.g., concept, design, data analysis, manuscript preparation).

Abstract and Keywords:

Original Articles: Structured abstract (300 words: Background, Methods, Results, Conclusions).

Review Articles: Indicative abstract (150–250 words).

Interesting Cases: Descriptive summary with a representative image.

Guidelines and Consensus: Abstract describing development, recommendations, and scope.

3–6 keywords for all manuscripts.

Images:

Submit as JPEG or TIFF files at 300 PPI (minimum 1800 × 1600 pixels).

Include legends (up to 40 words) at the end of the manuscript file.

Appendices: Include additional experimental data or technical details as supplementary materials.

Copyright

Transfer Form: Submit a signed form from all authors as a scanned image

via the submission system (https://jnmmi.theimms.com).

File Size Limit: Maximum 100 MB per uploaded file.

Manuscripts not adhering to these guidelines will be returned for correction before review.

Preparation of Manuscripts

Manuscripts

must follow the “International Committee of Medical Journal Editors

(ICMJE) Recommendations” and JNMMI’s specific requirements:

Language: Use American English consistently.

Font and Formatting: Use 11-point font, double-spaced, with page numbers at the bottom.

Abbreviations: Write out abbreviations in full at first use in the title, abstract, figure, and table.

Numerals: Spell out numbers 1–10 and all numbers at the start of sentences.

Structure for Original Articles:

Abstract: Structured (Background, Methods, Results, Conclusions; 300 words).

Introduction: State purpose and rationale, citing pertinent references.

Methods:

Describe participant selection, eligibility/exclusion criteria, and source population.

Detail methods, apparatus (with manufacturer details), and procedures for reproducibility.

Reference established methods; describe new or modified methods with justifications.

Specify drugs/chemicals (generic names, doses, routes).

For clinical trials, follow CONSORT guidelines and include trial registration details.

For

ethical considerations, confirm compliance with the Declaration of

Helsinki (2024 revision) for human studies or ARRIVE 2.0/AVMA guidelines

(2020) for animal studies. Include ethics committee approval and

informed consent details.

Statistics:

Quantify findings wherever possible and include appropriate measures of

uncertainty (e.g., confidence intervals). Report any losses to

observation (e.g., dropouts). Specify the statistical methods used in

the Results section. Avoid non-technical use of statistical terms such

as “random,” “normal,” “significant,” “correlation,” and “sample.”

Define all statistical terms, abbreviations, and symbols. Specify the

software used. Use uppercase italics for P values (e.g., P = 0.048), and

report exact P values. Present confidence intervals for mean

differences, proportions, odds ratios, and hazard ratios.

Results:

Present findings logically, emphasizing key results without repeating

table/figure data. Include absolute numbers and statistical methods

used.

Discussion:

Summarize key findings, strengths, limitations, implications,

controversies, and future directions. Avoid repeating

Introduction/Results or claiming priority for incomplete work.

References: Approximately 30 for original articles, up to 350 for comprehensive reviews, with most from the last 5 years.

Tables:

Number consecutively, provide brief titles, and place after references.

Use footnotes following this sequence of symbols: *, †, ‡, §, ||, ¶,

**, ††, ‡‡. Obtain permission for borrowed/adapted tables.

Figures:

Number consecutively, ensure 300 PPI resolution, and provide legends

(up to 40 words). Submit numerical data for graphs. Obtain permission

for previously published figures.

Patient

Privacy: Remove identifying information unless essential, with written

informed consent. Include a consent statement in the manuscript if

applicable.

References

Follow

the Vancouver style with DOIs where available. Number references

consecutively in the order they appear in the text, using superscript

Arabic numerals after punctuation. Abbreviate journal titles per Index

Medicus. List up to 6 authors; for more, use “et al.”. Avoid citing

abstracts, unpublished observations, or personal communications unless

essential.

Examples:

Journal:

Meng FG, Jia FM, Ren XH, Ge Y, Wang KL, Ma YS, et al. Vagus Nerve

Stimulation for Pediatric and Adult Patients with Pharmaco-resistant

Epilepsy. Chin Med J 2015;128:2599–2604. doi: 10.4103/0366-6999.166023.

Book:

Weinstein L, Swartz MN. Pathogenic properties of invading

microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic

physiology: mechanisms of disease. Philadelphia: Saunders; 1974:457–472.

Electronic

Source: Cumulative number of reported cases of severe acute respiratory

syndrome (SARS). Geneva: World Health Organization, 2003. Available

from: http://www.who.int/csr/sarscountry/2003_04_04/en/. [Last accessed

on 2003 April 9].

Clinical Trial Registry

JNMMI

requires registration of clinical trials. JNMMI will consider

publishing clinical trials that have been registered with a clinical

trial registry that allows free online access to the public.

Registration in the following trial registers is acceptable:

http://www.chictr.org.cn/; http://www.ctri.in/;

http://www.clinicaltrials.gov/; http://www.isrctn.org/;

http://www.trialregister.nl/trialreg/index.asp; and

http://www.umin.ac.jp/ctr and any registry that is a primary register of

the WHO International Clinical Trials Registry Platform (ICTRP;

www.who.int/ictrp/network/primary/en/index.html).

Data Sharing

Authors must include a data sharing statement indicating:

Whether individual deidentified participant data (including data dictionaries) will be shared.

The data in particular will be shared.

Availability of related documents (e.g., study protocol).

Data availability period and access criteria.

If no additional data are available, state: “Data sharing: no additional data available.”

See

ICMJE guidelines

(http://www.icmje.org/news-and-editorials/data_sharing_june_2017.pdf)

and DataCite (https://www.datacite.org/) for repositories.

Authorship Criteria

Per ICMJE Recommendations, authorship requires:

Substantial contributions to conception/design, data acquisition, analysis, or interpretation.

Drafting or critically revising the manuscript.

Final approval of the published version.

Accountability for all aspects of the work.

General

supervision, funding acquisition, or data collection alone does not

qualify. The corresponding author is responsible for communication and

revisions. Changes to authorship (order, addition, deletion) require

written consent from all authors.

Conflicts of Interest

Authors

must disclose financial or personal relationships that could influence

the research, including affiliations with products or institutions

mentioned in the manuscript. Include a conflict of interest statement on

the title page.

Ethical Guidelines

Human

Studies: Comply with the Declaration of Helsinki (2024 revision).

Provide ethics committee approval and informed consent (or assent for

children >7 years, per regional guidelines). Ensure patient

confidentiality.

Animal Studies: Follow ARRIVE 2.0 and AVMA Guidelines (2020) for anesthesia/euthanasia.

Consent

for Publication: Obtain written informed consent for identifiable

patient information or images. Authors must archive consent forms.

Unethical Research: Manuscripts reporting unethical research will not be considered.

Retraction Policy

JNMMI may retract articles for:

Unreliable findings (misconduct or honest error).

Redundant publication without proper reference.

Plagiarism.

Unethical research.

JNMMI follows COPE Retraction Guidelines (http://publicationethics.org/files/retraction%20guidelines_0.pdf).

Article Processing Charges (APC)

Upon acceptance, authors must pay an APC:

Authors from China: CHY 1,600 per page (based on final PDF), plus CHY 1,000 for color figures.

Authors outside China: USD 320 per page (including all figures).

Please

note: The APC for papers published from 2025 to 2027 will be fully

sponsored by the Affiliated Hospital of Jiangnan University.

Copyright and Licensing

Upon

acceptance, copyright transfers to JNMMI. Authors retain rights for

academic use with proper attribution. As an open-access journal,

articles are freely accessible worldwide.

Checklist for Submission

Covering Letter: Signed by all authors, mentioning prior publications/presentations, funding, and conflicts of interest.

Authors: Full names, affiliations, and corresponding author details provided. Identity not revealed in blinded manuscript file.

Format:

11-point font, page numbers, structured abstract (if applicable), 3–6

keywords, Vancouver-style references, no tracked changes.

Language: American English, full terms for abbreviations at first use, numerals 1–10 spelled out.

Tables/Figures: No data duplication, good quality (300 PPI), legends provided, permissions for borrowed material.

Ethics: Ethics committee approval, informed consent, and patient privacy maintained.

Copyright Form: Signed by all authors.

Contact Information

Editorial Office:

Email: jnmmi@cmaph.org

Website: under construction

Phone: +86 510 6808 8838

Additional Notes

JNMMI

reserves the right to edit manuscripts for clarity and readability,

consulting authors for major changes. Each issue is limited to 64 pages,

so early submission is encouraged to secure space in the quarterly

publication schedule. For further guidance, refer to:

ICMJE: http://www.icmje.org

EQUATOR Network: http://www.equator-network.org

COPE: http://publicationethics.org